Literature DB >> 11852256

The alpha(v)beta3 integrin, NF-kappaB, osteoprotegerin endothelial cell survival pathway. Potential role in angiogenesis.

Marta Scatena1, Cecilia Giachelli.   

Abstract

The growth and survival of many cell types requires integrin-mediated adhesion to the extracellular matrix (ECM). Physiologically, the prerequisite of cell-ECM adhesion interaction for cell cycle progression and cell survival is likely to be important in tissue morphology and regression as a mechanism to regulate tissue architecture and cell number. Pathologically, anchorage-dependent survival may limit tumor invasion and metastasis. Endothelial cells are anchorage-dependent cells, and many ECM molecules interacting with different classes of integrins promote their survival. It has became clear, however, that during the angiogenesis process the alpha(v)beta(3) integrin plays a fundamental role in maintaining endothelial cell viability. The downstream signals regulating this process are becoming clarified, and new functions are described for molecules involved in apparently distant systems.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11852256     DOI: 10.1016/s1050-1738(01)00151-7

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  17 in total

1.  Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension.

Authors:  Amit Noheria; Thomas H Mosley; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2010-03-25       Impact factor: 2.689

2.  Periostin Mediates Condylar Resorption via the NF-κB-ADAMTS5 Pathway.

Authors:  Baoting Fan; Xiaohan Liu; Xinwei Chen; Weifeng Xu; Huaqiang Zhao; Chi Yang; Shanyong Zhang
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

Review 3.  Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond.

Authors:  Maria V Deligiorgi; Mihalis I Panayiotidis; John Griniatsos; Dimitrios T Trafalis
Journal:  Clin Exp Metastasis       Date:  2019-10-01       Impact factor: 5.150

4.  Entamoeba histolytica cysteine proteinase 5 binds integrin on colonic cells and stimulates NFkappaB-mediated pro-inflammatory responses.

Authors:  Yongzhong Hou; Leanne Mortimer; Kris Chadee
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

5.  IL-1 is required for tumor invasiveness and angiogenesis.

Authors:  Elena Voronov; Dror S Shouval; Yakov Krelin; Emanuela Cagnano; Daniel Benharroch; Yoichiro Iwakura; Charles A Dinarello; Ron N Apte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-21       Impact factor: 11.205

6.  The homeobox gene GAX activates p21WAF1/CIP1 expression in vascular endothelial cells through direct interaction with upstream AT-rich sequences.

Authors:  Yun Chen; Alejandro D Leal; Sejal Patel; David H Gorski
Journal:  J Biol Chem       Date:  2006-10-30       Impact factor: 5.157

7.  Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma.

Authors:  Reiko Ito; Hirofumi Nakayama; Kazuhiro Yoshida; Kazuya Kuraoka; Junichi Motoshita; Noriko Oda; Naohide Oue; Wataru Yasui
Journal:  Virchows Arch       Date:  2003-06-28       Impact factor: 4.064

8.  Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinoma.

Authors:  Ali A Siddiqui; Elizabeth Jones; Darren Andrade; Apeksha Shah; Thomas E Kowalski; David E Loren; Galina Chipitsyna; Hwyda A Arafat
Journal:  J Gastroenterol Hepatol       Date:  2014-06       Impact factor: 4.029

Review 9.  Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily.

Authors:  Allan Flyvbjerg
Journal:  Nat Rev Endocrinol       Date:  2010-02       Impact factor: 43.330

10.  Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.

Authors:  A Jorsal; L Tarnow; A Flyvbjerg; H-H Parving; P Rossing; L M Rasmussen
Journal:  Diabetologia       Date:  2008-08-22       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.